Moreover, suppressing HOTAIR in combination with other epigenetic drugs (e.g., DZNep and AC1Q3QWB) showed a great promise in treatments for breast cancer and glioblastoma (Li et al., 2019; Sun et al., 2015). The gene discussed is HOTAIR; the disease is breast carcinoma.